Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting ...Middle East

– Four posters highlight TERLIVAZ research on the potential impact of dosing and outcomes in key subpopulations of adults with HRS with rapid reduction in kidney function1 – DUBLIN, Oct. 30, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced...

Hence then, the article about mallinckrodt to present data on terlivaz terlipressin for injection at the 2024 american association for the study of liver diseases aasld annual meeting was published today ( Wednesday 30/10/2024 - 01:57 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting )

Also on site :

• This Airline Just Upgraded Premium Economy With Full Privacy Screens, Electric Recline, and Wireless Charging
• France Launches Global Initiatives to Support Independent Cinema and Establish Framework for Alliance of State Film Commissions: Lumiere Summit
• JLR set to reveal thousands of job losses amid £1.7bn cost-cutting overhaul